ReviewCurrent oncology (Toronto, Ont.)2022

Bone Targeting Agents in Patients with Prostate Cancer: General Toxicities and Osteonecrosis of the Jaw.

Veronica Mollica et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.